Swine Flu fear boost Biotechs

by | Apr 27, 2009 | BIOgraph

The U.S. Government declared an emergency Sunday and released 25% of Relenza and Tamiflu antiviral treatment courses for use by healthcare providers should cases escalate. Tamiflu was developed by Gilead and manufactured and sold by Roche; Relenza is made by...

Macro Reflation trade: Deflation risk persists

An April 14 story on Bloomberg said that the ECB may have to lower interest rates below 1.25% next month to counter the worse recession in six decades. And the FED continued its quantitative easing Monday purchasing $7.37B in Treasuries and $5.15 B in Agency debt....

Q1 Biotechnology Update

The March rally improved the performance of the Life Science sector in Q1 but trailed gains in the technology sector. The S&P Healthcare Index lost 8.5% in Q1 compared to the S&P 500 loss of 11.7%. The S&P Technology Sector gained about 2% in 2009. The...

Pin It on Pinterest